Kappa Bioscience Creates End-to-End Solution with Acquisition of ppm.Ingredients

ae51a05c-1988-4917-8920-bf18a47e0ac8articleimage.jpg

17 Jan 2017 --- Kappa Bioscience AS, maker of K2VITAL vitamin K2 MK-7 has announced the acquisition of ppm.Ingredients KG (PPM), its long term European distributor. PPM will continue operations as Kappa Ingredients GmbH, effective immediately.

By integrating a sales function, Kappa increases its overall competitiveness with the ability to work more closely with customers and partners. PPM supplies more than 100 different grades of four complementary ingredients: Vitamin K2 as MK-7, Calcium, Magnesium and Vitamin D3. Vitamin K2 products are marketed under the K2VITAL portfolio, including the microencapsulated K2VITAL DELTA. The acquisition instantly expands Kappa’s product line and increases its in-house expertise of market solutions for bone and heart health products. This acquisition follows an earlier 2016 acquisition of Synthetica AS, another long-term partner specializing in drug and vitamin synthesis, analysis, and research and development.

Together, these acquisitions are significant for Kappa and the K2 industry as a whole, because it now provides Kappa with full ownership of the value chain, from development through production to finished formulations. The combined acquisitions also give Kappa the ability to develop and serve the wider ingredients marketplace.

Kappa will continue commercial operations as the parent company while operating three divisions. Kappa Ingredients will focus on sales and marketing of the K2VITAL and other product lines, Kappa Chemistry will continue R&D and production and offer custom organic synthesis services, and Kappa Analytics will offer analytical services and K2 reference samples.  

Egil Greve, CEO of Kappa Bioscience, says: “This is a very important acquisition for Kappa Bioscience because we are the first company in our industry to create an end-to-end solution, from molecule development and production via R&D to finished formulation or dosage format.” Greve continues, “The highly experienced and well-respected team at PPM will be a huge asset, not just in terms of continued market expansion, but also in the knowledge of vitamin K2 and how our customers can develop the category and promote the very important health benefits of K2. Though we are already the market leader, this increases our competitiveness and will help us fulfill our vision of bringing K2 to every consumer segment in every market channel.”

Jörg Büttinghaus of ppm.Ingredients says: “We are very pleased to join the leading producer of vitamin K2 and by doing so expand the Kappa product line and Kappa’s ability to innovate customer solutions. We are equally excited to join a company with deep R&D experience and analytical services capabilities as this further expands how we can work with customers and partners.” Büttinghaus continues, “The K2 market is doubling in size each year, but is still relatively small.  We see Kappa as the company with the scope and resources push K2 to the tipping point where we would see a development trajectory similar to what the market has seen with vitamin D3.”

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Food Ingredients News

Healthy aging and bone health at HiE 2018: Calcium carbonates, vitamin K2 and resveratrol among key ingredients

30 Nov 2018 --- Due to the aging of the world’s population, there is an ongoing trend towards the enrichment of foods and beverages to avoid or prevent the health problems associated with growing older. At this year’s HiE in Frankfurt, Germany, bone health and senior nutrition were key themes and ingredient suppliers such as Omya, Faravelli and Evolva were keen to discuss their latest concepts which help target the growing trend for improving healthy aging.

Health & Nutrition News

Weekly Roundup: BioCell Collagen featured in Joint Support launch, Nutritional benefits of grass-fed dairy highlighted

26 Oct 2018 --- This week in nutrition, BioCell Collagen is featured in a product launch by Bluebonnet Targeted Choice, coined Joint Support. Rupa Das, BI’s Vice President of Global Quality and Compliance, was appointed as the interim chair for the American Herbal Products Association Board of Trustees. A Teagasc organized “Grass-Fed Dairy Conference” highlighted the benefits of grass-fed dairy systems on the nutritional composition of dairy products and a NattoPharma ASA sponsored symposium in the Netherlands examined the impact of vitamin K2 on arteries and bones.

Health & Nutrition News

Joint health: “boomer” and “millennial” demographics hold future potential, says Lonza exec

19 Oct 2018 --- The global market for joint health supplements is increasing, driven by the large “baby boomer” population seeking to maintain their mobility and the high rate of supplement use among “millennials.” This is according to Dominik Mattern, Associate Director and Head of Business Development at Lonza. During a NutritionInsight webinar presented yesterday, entitled Driving growth in the joint health category: UC-II undenatured Type II collagen for joint support, Mattern highlighted the shifting market dynamics which is supporting the popularity of ingredients for joint health such as Lonza's UC-II undenatured Type II collagen.

Health & Nutrition News

Weekly Roundup: Enzybel Pharma partners with Terhormon on pancreatin, Nuritas forms scientific advisory board

12 Oct 2018 ---- Enzybel Pharma has partnered with Terhormon to “take the lead” on the pancreatin market, while Fermentalg has signed new agreements with the SUEZ group for the development of its algal biofilter. Valensa has adopted saw palmetto through the American Botanical Council’s (ABC) Adopt-an-Herb botanical education program, and the American Herbal Products Association (AHPA) has requested that pullulan be allowed in dietary supplements labeled as organic. VitaMK7, the fermented vitamin K2 as MK7, can offer more than four years of extended stability at room temperature. Research has identified benefits Sabinsa’s Curcumin C3 Complex and BioPerine Combination can bring to diabetics. Nuritas has appointed four key additions to its newly formed scientific advisory board.

Health & Nutrition News

Weekly Roundup: KitoZyme to exhibit exclusive range of biopolymer blends, Bifodan expands microbiology lab in Denmark

28 Sep 2018 --- The weekly roundup is NutritionInsight's collection of global nutrition stories from the past week. OmegaQuant has opened a new testing lab for the Asia-Pacific region, Bifodan has expanded with a new microbiology laboratory in Denmark and Botanic Innovations is doubling its facility size to increase production. Gnosis is positioning its VitaMK7, the vitamin K2 as Menaquinone-7 (MK7), as clean label. KitoZyme is set to exhibit its exclusive range of biopolymer blends coined You Are Wonderful (YAW), at CPHI Madrid in October.

More Articles
URL : http://www.nutritioninsight.com:80/news/Kappa-Bioscience-Creates-End-to-End-Solution-with-Acquisition-of-ppmIngredients.html